Literature DB >> 8515909

Oral contraceptive risk assessment: a survey of 247 educated women.

J F Peipert1, J Gutmann.   

Abstract

OBJECTIVE: To determine womens' beliefs regarding the risks and health benefits of oral contraceptives (OCs).
METHODS: Between April 26 and June 7, 1991, 247 women completed a self-administered questionnaire at the Yale University Health Services evaluating their perceptions of the risks and benefits of OC agents.
RESULTS: The mean age of the study population was 30.2 years (range 16-68), and more than 90% of the study group had at least 1 year of college education. Forty-nine percent of the study group believed there are substantial risks to OC use. Between 80-95% of women were unaware of the following health benefits of OCs: decreased risks of endometrial cancer, ovarian cancer, pelvic inflammatory disease, ectopic pregnancy, anemia, and benign breast disease.
CONCLUSIONS: Perceptions of the risks of OCs are exaggerated and there is a clear knowledge deficit with regard to their health benefits. Increased educational efforts by health care providers should emphasize the health benefits of OCs and attempt to dispel the common misconceptions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8515909

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Topics for our times: Norplant coercion--an overstated threat.

Authors:  A R Davidson; D Kalmuss
Journal:  Am J Public Health       Date:  1997-04       Impact factor: 9.308

2.  Conditionally reprogrammed macaque endocervical cells retain steroid receptor expression and produce mucus.

Authors:  Leo Han; Walker Andrews; Karsten Wong; Jeffrey T Jensen
Journal:  Biol Reprod       Date:  2020-05-26       Impact factor: 4.285

3.  Syntheses of PDE3A inhibitor ORG9935 and determination of the absolute stereochemistries of its enantiomers by X-ray crystallography.

Authors:  Sudhakar Jakkaraj; Victor G Young; Gunda I Georg
Journal:  Tetrahedron       Date:  2018-04-18       Impact factor: 2.457

4.  Blocking serine protease activity prevents semenogelin degradation leading to hyperviscous semen in humans.

Authors:  Prashanth Anamthathmakula; Jeffery A Erickson; Wipawee Winuthayanon
Journal:  Biol Reprod       Date:  2022-05-17       Impact factor: 4.161

5.  The phosphodiesterase 3 inhibitor ORG 9935 inhibits oocyte maturation in the naturally selected dominant follicle in rhesus macaques.

Authors:  Jeffrey T Jensen; Mary B Zelinski; Jessica E Stanley; John W Fanton; Richard L Stouffer
Journal:  Contraception       Date:  2008-03-04       Impact factor: 3.375

6.  Medical contraindications in women seeking combined hormonal contraception.

Authors:  Hanna Xu; David L Eisenberg; Tessa Madden; Gina M Secura; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2013-11-16       Impact factor: 8.661

7.  Evaluation of the phosphodiesterase 3 inhibitor ORG 9935 as a contraceptive in female macaques: initial trials.

Authors:  Jeffrey T Jensen; Richard L Stouffer; Jessica E Stanley; Mary B Zelinski
Journal:  Contraception       Date:  2009-11-06       Impact factor: 3.375

8.  Mechanism of semen liquefaction and its potential for a novel non-hormonal contraception†.

Authors:  Prashanth Anamthathmakula; Wipawee Winuthayanon
Journal:  Biol Reprod       Date:  2020-08-04       Impact factor: 4.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.